UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A phase I dose escalation study of oral c-MET inhibitor tivantinib (ARQ 197) in combination with gemcitabine in patients with solid tumors

Annals of oncology, 2014-07, Vol.25 (7), p.1416-1421

2014

Volltextzugriff (PDF)

A Phase-1b study of tivantinib (ARQ 197) in adult patients with hepatocellular carcinoma and cirrhosis

British journal of cancer, 2013-01, Vol.108 (1), p.21-24

2013

Volltextzugriff (PDF)

Phase II trial of imatinib mesylate in patients with metastatic melanoma

British journal of cancer, 2008-09, Vol.99 (5), p.734-740

2008

Volltextzugriff (PDF)

Pilot study of combination transcriptional modulation therapy with sodium phenylbutyrate and 5-azacytidine in patients with acute myeloid leukemia or myelodysplastic syndrome

Leukemia, 2006-02, Vol.20 (2), p.212-217

2006

Volltextzugriff (PDF)

Phase I study of the effects of renal impairment on the pharmacokinetics and safety of satraplatin in patients with refractory solid tumors

Annals of oncology, 2012-04, Vol.23 (4), p.1037-1044

2012

Volltextzugriff (PDF)

Leukocytosis and the Retinoic Acid Syndrome in Patients With Acute Promyelocytic Leukemia Treated With Arsenic Trioxide

Journal of clinical oncology, 2000-07, Vol.18 (13), p.2620-2625

2000

Volltextzugriff (PDF)

Clinical applications of retinoids in cancer medicine

Journal of biological regulators and homeostatic agents, 2003-01, Vol.17 (1), p.98

Camacho, L H

2003

Volltextzugriff (PDF)

The eosinophilic response and haematological recovery after treatment for Plasmodium falciparum malaria

Tropical medicine & international health, 1999-07, Vol.4 (7), p.471-475

1999

Volltextzugriff (PDF)

Antitumor Activity in Melanoma and Anti-Self Responses in a Phase I Trial With the Anti-Cytotoxic T Lymphocyte–Associated Antigen 4 Monoclonal Antibody CP-675,206

Journal of clinical oncology, 2005-12, Vol.23 (35), p.8968-8977

2005

Volltextzugriff (PDF)

Biologic and immunomodulatory events after CTLA‐4 blockade with ticilimumab in patients with advanced malignant melanoma

Cancer, 2006-06, Vol.106 (11), p.2437-2444

2006

Volltextzugriff (PDF)

Phase Ib results of c-MET inhibitor ARQ 197 in combination with gemcitabine in a cohort of patients (pts) with advanced breast, ovarian, and uterine tumors

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.3077-3077

2011

Volltextzugriff (PDF)

Hepatic resection for metastatic melanoma: distinct patterns of recurrence and prognosis for ocular versus cutaneous disease

Annals of surgical oncology, 2006-05, Vol.13 (5), p.712-720

2006

Volltextzugriff (PDF)

A phase I study of palifosfamide in combination with doxorubicin: Safety and preliminary efficacy

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.10577-10577

2009

Volltextzugriff (PDF)

Phase Ib dose-escalation trial evaluating c-MET inhibitor ARQ 197 administered in combination with gemcitabine to patients (pts) with advanced solid tumors

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.e13008-e13008

2010

Volltextzugriff (PDF)

Presentation and subsequent publication rates of phase I oncology clinical trials

Cancer, 2005-10, Vol.104 (7), p.1497-1504

2005

Volltextzugriff (PDF)

Final results from ARQ 197-114: A phase Ib safety trial evaluating ARQ 197 in cirrhotic patients (pts) with hepatocellular carcinoma (HCC)

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.4137-4137

2010

Volltextzugriff (PDF)

Evaluation of indibulin, a novel tubulin targeting-agent, in combination with capecitabine, with mathematically optimized dose scheduling

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.2538-2538

2009

Volltextzugriff (PDF)

Dual inhibition of VEGF pathway: Phase I trial of bevacizumab and cediranib in advanced solid tumors

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.3065-3065

2011

Volltextzugriff (PDF)

The course of anaemia after the treatment of acute, falciparum malaria

Annals of tropical medicine and parasitology, 1998-07, Vol.92 (5), p.525-537

1998

Volltextzugriff (PDF)

A phase II trial of arsenic trioxide in patients with metastatic melanoma

Cancer, 2005-10, Vol.104 (8), p.1687-1692

2005

Volltextzugriff (PDF)

A phase I study of imexon in combination with docetaxel (DOC) for the treatment of patients with breast, lung and prostate cancer

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.3589-3589

2008

Volltextzugriff (PDF)

Expanding the genetic potential of the soybean

Journal of the American Oil Chemists' Society, 1981-03, Vol.58 (3), p.125-127

Camacho, L.H

1981

Volltextzugriff (PDF)

A phase I dose-escalation study of the safety and pharmacokinetics (PK) of XL184, a VEGFR and MET kinase inhibitor, administered orally to patients (pts) with advanced malignancies

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.14031-14031

2007

Volltextzugriff (PDF)

Phase I dose-escalation study of sodium stibogluconate (SSG), a protein tyrosine phosphatase inhibitor, combined with interferon-alfa for patients with solid tumors

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.3011-3011

2008

Volltextzugriff (PDF)

First in human phase I study of MK-2461, a small molecule inhibitor of c-Met, for patients with advanced solid tumors

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.14657-14657

2008

Volltextzugriff (PDF)

1 – 25 von 1.655

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.367)
Mit Volltextzugriff
(1.500)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(756)
Physics
(422)
Life Sciences & Biomedicine
(374)
Physical Sciences
(300)
Humans
(279)
Female
(175)
Male
(171)
High Energy Physics - Experiment
(162)
Technology
(130)
Astronomy & Astrophysics
(107)
Physics Of Elementary Particles And Fields
(102)
Biological And Medical Sciences
(99)
Physics, Particles & Fields
(97)
Adult
(92)
Middle Aged
(89)
Medical Sciences
(72)
Aged
(69)
Animals
(67)
Exact Sciences And Technology
(67)
Nuclear Physics And Radiation Physics
(63)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

A phase I dose escalation study of oral c-MET inhibitor tivantinib (ARQ 197) in combination with gemcitabine in patients with solid tumors

A Phase-1b study of tivantinib (ARQ 197) in adult patients with hepatocellular carcinoma and cirrhosis

Phase II trial of imatinib mesylate in patients with metastatic melanoma

Pilot study of combination transcriptional modulation therapy with sodium phenylbutyrate and 5-azacytidine in patients with acute myeloid leukemia or myelodysplastic syndrome

Phase I study of the effects of renal impairment on the pharmacokinetics and safety of satraplatin in patients with refractory solid tumors

Leukocytosis and the Retinoic Acid Syndrome in Patients With Acute Promyelocytic Leukemia Treated With Arsenic Trioxide

Clinical applications of retinoids in cancer medicine

The eosinophilic response and haematological recovery after treatment for Plasmodium falciparum malaria

Antitumor Activity in Melanoma and Anti-Self Responses in a Phase I Trial With the Anti-Cytotoxic T Lymphocyte–Associated Antigen 4 Monoclonal Antibody CP-675,206

Biologic and immunomodulatory events after CTLA‐4 blockade with ticilimumab in patients with advanced malignant melanoma

Phase Ib results of c-MET inhibitor ARQ 197 in combination with gemcitabine in a cohort of patients (pts) with advanced breast, ovarian, and uterine tumors

Hepatic resection for metastatic melanoma: distinct patterns of recurrence and prognosis for ocular versus cutaneous disease

A phase I study of palifosfamide in combination with doxorubicin: Safety and preliminary efficacy

Phase Ib dose-escalation trial evaluating c-MET inhibitor ARQ 197 administered in combination with gemcitabine to patients (pts) with advanced solid tumors

Presentation and subsequent publication rates of phase I oncology clinical trials

Final results from ARQ 197-114: A phase Ib safety trial evaluating ARQ 197 in cirrhotic patients (pts) with hepatocellular carcinoma (HCC)

Evaluation of indibulin, a novel tubulin targeting-agent, in combination with capecitabine, with mathematically optimized dose scheduling

Dual inhibition of VEGF pathway: Phase I trial of bevacizumab and cediranib in advanced solid tumors

The course of anaemia after the treatment of acute, falciparum malaria

A phase II trial of arsenic trioxide in patients with metastatic melanoma

A phase I study of imexon in combination with docetaxel (DOC) for the treatment of patients with breast, lung and prostate cancer

Expanding the genetic potential of the soybean

A phase I dose-escalation study of the safety and pharmacokinetics (PK) of XL184, a VEGFR and MET kinase inhibitor, administered orally to patients (pts) with advanced malignancies

Phase I dose-escalation study of sodium stibogluconate (SSG), a protein tyrosine phosphatase inhibitor, combined with interferon-alfa for patients with solid tumors

First in human phase I study of MK-2461, a small molecule inhibitor of c-Met, for patients with advanced solid tumors

Suchergebnisse filtern